TalkSooner and Baldwin Community School collaborate on youth vaping education

Sep.02.2022
TalkSooner and Baldwin Community School collaborate on youth vaping education
TalkSooner works with Michigan schools to educate parents and teens about the dangers and risks of electronic cigarette addiction.

As the number of teenagers vaping across the United States continues to rise, many school districts in West Michigan are taking measures to educate families about the dangers of addiction, including the Baldwin Community Schools.


TalkSooner is an organization dedicated to helping parents and teenagers understand the dangers of drug abuse. They are currently working in collaboration with Baldwin School to educate and facilitate discussions on the topic of teen use of electronic cigarettes.


This organization is a cooperative organization between Allegan County, Berrien County, Kent County, Muskegon County, and Ottawa County in western Michigan. It is coordinated by the West Michigan Shoreline Regional Development Commission (now known as the West Michigan Shoreline Regional Entity).


Recently, the organization partnered with the Baldwin Community School to launch a new education tool that will serve those who can provide information on e-cigarette use for teenagers.


This vehicle made its debut in the area on August 24th. The car displays information in English on one side and in Spanish on the other side through TalkSooner.


According to data from the 2018 National Youth Tobacco Survey (NYTS), the use of electronic cigarettes among current middle and high school students increased by 48% between 2017 and 2018. As of 2018, over 3.6 million children are currently using electronic cigarettes.


Griffin stated, "If you look at smoking, we almost didn't see the number of people smoking in the 50s and 60s because we not only had prevention, but education," Griffin said. "We now know smoking brings harm and can change our lives. We hope to ensure that we take the same measures for children who start vaping at 13 or 14 years old, to catch and quit this habit early or at least make them aware of the dangers that come with it.


On June 4, 2019, Governor Gretchen Whitmer signed Senate Bills 106 and 155, prohibiting the sale and possession of electronic cigarettes to anyone under the age of 18. In December of the same year, federal legislation was signed, raising the legal age to purchase or use tobacco products, including e-cigarettes, to 21. Despite these measures, many remain skeptical of the number of young students still using e-cigarettes.


Griffin has seen firsthand how difficult it is for parents to talk to teenagers about using e-cigarettes after her own child used them. "Preventative education seems to be the most important, not just for your physical health, but also for your mental and overall well-being," she said. "Even in the most educated households, there is still susceptibility to the pressures of e-cigarettes and such. I always encourage parents to have open conversations with their children, discussing their own struggles or choices made by young people. I also suggest trying to find out why they are interested in e-cigarettes or the root cause of their decision to use them.


In September 2018, the US Food and Drug Administration (FDA) sent over 1,300 warning letters and civil monetary penalties to retailers illegally selling e-cigarette products to minors, with the majority being blu, JUUL, Logic, MarkTen XL, and Vuse; this marked the FDA's largest coordinated enforcement effort to date.


According to the Centers for Disease Control and Prevention, some e-cigarette products have labels that do not disclose that they contain nicotine, while some e-cigarette liquids marketed as containing 0% nicotine have been found to contain nicotine.


Using nicotine during adolescence can damage the parts of the brain that control attention, learning, emotions, and impulse control, and may also impair brain development in teenagers. This damage can persist into the mid-20s.


Statement


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not reflect the views of 2FIRSTS and we cannot verify the accuracy or truthfulness of its contents. The compilation of this article is only intended for industry-related research and exchange.


Due to limitations in the level of translation, the translated article may not express exactly the same meaning as the original. Please refer to the original text for accuracy.


2FIRSTS fully aligns its statements and position with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or international issues.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Philippines Mandates Safety Certification for Nicotine Pouches, Gives Industry 12 Months to Comply
Philippines Mandates Safety Certification for Nicotine Pouches, Gives Industry 12 Months to Comply
The Philippines Department of Trade and Industry has placed nicotine pouches under mandatory product certification through Department Administrative Order No. 26-07, Series of 2026. Nicotine pouches must obtain a Philippine Standard, or PS, license before they can be manufactured, imported, packed, distributed or sold in the country. The regime requires testing for nicotine content, pH and water activity, while packaging must disclose nicotine strength, ingredients, allergens, batch information, the PS certification mark and prescribed health warnings. Existing market participants have a 12-month transition period to comply.
Regulations
Oct.12
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania's Act 57 vape directory regime will reach the end of its 120-day inventory transition period on Oct. 19. Nicotine-containing e-cigarettes intended for retail sale in the state that are not listed on the Attorney General's ENDS directory will then be barred from retail sale and treated as contraband subject to seizure, forfeiture and destruction. Manufacturers face annual product certification, brand- and style-based fees and a minimum $50,000 surety bond, while retailers and wholesalers must source through licensed channels and monitor the directory.
Regulations
Oct.08
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Philip Morris International (PMI) has launched ZYN Melts in the UK, introducing a fully dissolvable oral nicotine tablet format alongside the brand's existing nicotine pouches. The range includes Cool Mint and Peppermint, each offered at 1mg and 2mg of nicotine per tablet, creating four SKUs. Each can contains 20 tablets and is priced at £6.50 in the UK. Unlike ZYN nicotine pouches, Melts are placed between the upper lip and gum and dissolve completely during use.
News
Sep.29 by 2Firsts Perspectives
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03